Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...
We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...
Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...
Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to ... ALXO), a clinical-stage biotechnology company advancing therapies ...
EU targets AI, biotech, green tech, advance materials sectors Draghi report said EU is falling behind US and China France, Trump push EU to cut business red tape EU plans include 25% reduction of ...
On Friday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.38 which represents a decrease of $-0.11 or -3.15% from the prior close of $3.49. The stock opened at $3.49 and ...
Dec. 17, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing ... seen with systemic anti-CD47 blockade ZURICH-SCHLIEREN ...
US clinical-stage immuno-oncology biotech ALX Oncology Holdings (Nasdaq: ALXO) released positive updated data from the ASPEN-06 Phase II clinical trial demonstrating that its investigational ...